BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15124248)

  • 1. Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis.
    Hartman M; van Ede A; Severens JL; Laan RF; van de Putte L; van der Wilt GJ
    J Rheumatol; 2004 May; 31(5):902-8. PubMed ID: 15124248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE
    Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
    Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J;
    Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
    Morgan SL; Baggott JE; Lee JY; Alarcón GS
    J Rheumatol; 1998 Mar; 25(3):441-6. PubMed ID: 9517760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid and folinic acid supplementation during low-dose methotrexate therapy for rheumatoid arthritis: comment on the article by van Ede et al.
    Morgan SL; Baggott JE; Alarcón GS; Koopman WJ
    Arthritis Rheum; 2002 May; 46(5):1413-4. PubMed ID: 12115259
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.
    van Ede AE; Laan RF; Rood MJ; Huizinga TW; van de Laar MA; van Denderen CJ; Westgeest TA; Romme TC; de Rooij DJ; Jacobs MJ; de Boo TM; van der Wilt GJ; Severens JL; Hartman M; Krabbe PF; Dijkmans BA; Breedveld FC; van de Putte LB
    Arthritis Rheum; 2001 Jul; 44(7):1515-24. PubMed ID: 11465701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis.
    Morgan SL; Oster RA; Lee JY; Alarcón GS; Baggott JE
    Arthritis Rheum; 2004 Oct; 50(10):3104-11. PubMed ID: 15476202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.
    Whittle SL; Hughes RA
    Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation.
    Jensen OK; Rasmussen C; Mollerup F; Christensen PB; Hansen H; Ekelund S; Thulstrup AM
    J Rheumatol; 2002 Aug; 29(8):1615-8. PubMed ID: 12180718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
    Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial.
    Kobelt G; Lindgren P; Singh A; Klareskog L
    Ann Rheum Dis; 2005 Aug; 64(8):1174-9. PubMed ID: 15708879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis.
    Buckley LM; Vacek PM; Cooper SM
    J Rheumatol; 1990 Sep; 17(9):1158-61. PubMed ID: 2132565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
    van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
    Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study.
    Hunt PG; Rose CD; McIlvain-Simpson G; Tejani S
    J Rheumatol; 1997 Nov; 24(11):2230-2. PubMed ID: 9375889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis.
    Hoekstra M; van de Laar MA; Bernelot Moens HJ; Kruijsen MW; Haagsma CJ
    J Rheumatol; 2003 Nov; 30(11):2325-9. PubMed ID: 14677172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Ghogomu ET; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    J Rheumatol; 2014 Jun; 41(6):1049-60. PubMed ID: 24737913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
    Korthals-de Bos I; Van Tulder M; Boers M; Verhoeven AC; Adèr HJ; Bibo J; Boonen A; Van Der Linden S
    J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of comedication with folic or folinic acid on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a randomized, double blind, placebo controlled study of 48 weeks].
    Jansen TL; Spoorenberg A; Houtman PM; van Roon EN
    Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2168; author reply 2168. PubMed ID: 12474559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.